.Ascendis Pharma has actually become a prospective risk to BioMarin's Voxzogo, disclosing phase 3 gr...
.Though Alkeus Pharmaceuticals' dental eye ailment asset stopped working to dramatically reduce geog...
.With a trio of biotechs reaching the Nasdaq on Friday, it was effortless to miss out on a smaller-s...
.Immune system checkpoint preventions are actually the superheroes of cancer cells therapy. Medicine...
.Invite to recently's Chutes & Ladders, our summary of considerable leadership hirings, firings a...
.Regeneron is back along with lasting follow-up for its own LAG-3 inhibitor as well as PD-1 inhibito...
.AstraZeneca has actually discussed a very early consider the efficiency of its in-house antibody-dr...
.After announcing a phase 3 launch based on positive midstage outcomes, iTeos as well as GSK are fin...
.The FDA must be actually much more open as well as joint to discharge a rise in commendations of un...
.It's an uncommonly active Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bicara ...